Current research on CYP2C9 focuses on understanding its role in drug metabolism, identifying genetic polymorphisms that affect its activity, and developing strategies to personalize drug therapy. Studies also explore the enzyme's involvement in disease mechanisms and its potential as a biomarker for drug response and toxicity.
